
Fortress Biotech, Inc.
FBIOHealthcare|Biotechnology|US
$1.85
+0.01 (+0.54%)
Tangible Book / Share
$5.70
Graham Number
$20.29
Cash / Share
$6.21
Next Earnings Report
Nov 16, 2026
EPS est. -$0.27 · Revenue est. $21.6M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Dec 18, 2025 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026
Nov 5, 2026 · GlobeNewsWire
Journey Medical Corporation to Participate in September 2026 Investor Conferences
Sep 8, 2026 · GlobeNewsWire
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 · GlobeNewsWire
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Aug 13, 2026 · GlobeNewsWire
SEC Filings (65)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 29, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 1, 2026 | 8-K | Material event | DocumentIndex |
| Sep 1, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 14, 2026 | 8-K | Material event | DocumentIndex |
| Apr 28, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 28, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 30, 2026 | 8-K | Material event | DocumentIndex |
| Mar 20, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Feb 23, 2026 | 8-K | Material event | DocumentIndex |
| Jan 13, 2026 | 8-K | Material event | DocumentIndex |
| Jan 6, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jan 5, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Dec 18, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Dec 17, 2025 | EFFECT | DocumentIndex | |
| Dec 16, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Dec 15, 2025 | 8-K | Material event | DocumentIndex |
| Dec 15, 2025 | 8-K | Material event | DocumentIndex |
| Nov 17, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 14, 2025 | 8-K | Material event | DocumentIndex |
| Oct 1, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 1, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2025 | 8-K | Material event | DocumentIndex |
| Aug 1, 2025 | 424B7 | Offering prospectus | DocumentIndex |
| Jul 16, 2025 | 8-K | Material event | DocumentIndex |
| Jun 23, 2025 | 8-K | Material event | DocumentIndex |
| Jun 5, 2025 | 8-K | Material event | DocumentIndex |
| Jun 3, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| May 15, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2025 | 8-K | Material event | DocumentIndex |
| Apr 28, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 28, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |